VEGFR
VEGFR (Vascular Endothelial Growth Factor Receptor) inhibitors are compounds that block the signaling of VEGFR, a key receptor in the VEGF pathway, which is crucial for angiogenesis. VEGFR inhibitors prevent the formation of new blood vessels that supply nutrients and oxygen to tumors, thereby inhibiting tumor growth. These inhibitors are widely used in cancer therapy and research to study the mechanisms of angiogenesis and develop anti-cancer treatments. At CymitQuimica, we provide a comprehensive range of high-quality VEGFR inhibitors to support your research in oncology, vascular biology, and angiogenesis.
Read more
R1530
CAS:882531-87-5
R1530 is a multikinase inhibitor with antineoplastic and antiangiogenesis activities.
Formula:
C18H14ClFN4O
Purity:
97.96%
Color and Shape:
Solid
Molecular weight:
356.78
Ref: TM-TQ0317
| 1mg | 52.00 € | ||
| 2mg | 74.00 € | ||
| 5mg | 110.00 € | ||
| 10mg | 166.00 € | ||
| 25mg | 324.00 € | ||
| 50mg | 552.00 € | ||
| 100mg | 796.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ribociclib
CAS:1211441-98-3
Ribociclib (LEE011) is an orally available, and highly specific CDK4/6 inhibitor (IC50:10/39 nM).
Formula:
C23H30N8O
Purity:
100% - 99.96%
Color and Shape:
Solid
Molecular weight:
434.54
Ref: TM-T6199
| 2mg | 42.00 € | ||
| 5mg | 64.00 € | ||
| 10mg | 86.00 € | ||
| 25mg | 97.00 € | ||
| 50mg | 116.00 € | ||
| 100mg | 168.00 € | ||
| 500mg | 412.00 € | ||
| 1mL*10mM (DMSO) | 69.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
SAR131675
CAS:1433953-83-3
SAR131675 is a potent and selective VEGFR3 inhibitor with an IC50 of 23 nM.
Formula:
C18H22N4O4
Purity:
97.52% - 99.68%
Color and Shape:
Solid
Molecular weight:
358.39
Ref: TM-T6012
| 1mg | 36.00 € | ||
| 5mg | 72.00 € | ||
| 10mg | 111.00 € | ||
| 25mg | 221.00 € | ||
| 50mg | 337.00 € | ||
| 100mg | 504.00 € | ||
| 200mg | 606.00 € | ||
| 1mL*10mM (DMSO) | 85.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Nintedanib esylate
CAS:656247-18-6
Nintedanib esylate (BIBF 1120 esylate) is a potent triple angiokinase inhibitor for VEGFR1/2/3, FGFR1/2/3 and …
Formula:
C31H33N5O4·C2H6O3S
Purity:
99.43% - 99.96%
Color and Shape:
Solid
Molecular weight:
649.76
Ref: TM-T5001
| 5mg | 42.00 € | ||
| 10mg | 57.00 € | ||
| 25mg | 70.00 € | ||
| 50mg | 83.00 € | ||
| 100mg | 103.00 € | ||
| 200mg | 161.00 € | ||
| 500mg | 310.00 € | ||
| 1mL*10mM (DMSO) | 63.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Treprostinil Sodium
CAS:289480-64-4
Treprostinil Sodium (UT-15) is a potent DP1, IP and EP2 agonist (EC50: 0.6/1.9/6.2 nM).
Formula:
C23H33NaO5
Purity:
99.95%
Color and Shape:
Solid
Molecular weight:
412.5
Ref: TM-T5171
| 1mg | 51.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 138.00 € | ||
| 25mg | 268.00 € | ||
| 50mg | 434.00 € | ||
| 1mL*10mM (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Ki20227
CAS:623142-96-1
Ki-20227 is a specific c-Fms tyrosine kinase(CSF1R) inhibitor (IC50: 2 nM).
Formula:
C24H24N4O5S
Purity:
97.16% - 99.37%
Color and Shape:
Solid
Molecular weight:
480.54
Ref: TM-T4315
| 1mg | 46.00 € | ||
| 5mg | 94.00 € | ||
| 10mg | 152.00 € | ||
| 25mg | 279.00 € | ||
| 50mg | 458.00 € | ||
| 100mg | 730.00 € | ||
| 200mg | 994.00 € | ||
| 1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Tyrphostin A9
CAS:10537-47-0
Tyrphostin A9 (SF 6847) is an Agricultural acaricide, now superseded. Tyrphostin A9 is firstly designed …
Formula:
C18H22N2O
Purity:
98.21% - 99.36%
Color and Shape:
Yellow Solid
Molecular weight:
282.38
Ref: TM-T2479
| 25mg | 54.00 € | ||
| 50mg | 63.00 € | ||
| 100mg | 95.00 € | ||
| 200mg | 169.00 € | ||
| 500mg | 374.00 € | ||
| 1mL*10mM (DMSO) | 36.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
LY2874455
CAS:1254473-64-7
LY2874455 has been used in trials studying the treatment of Advanced Cancer.
Formula:
C21H19Cl2N5O2
Purity:
97.22% - 99.46%
Color and Shape:
Solid
Molecular weight:
444.31
Ref: TM-T2361
| 1mg | 63.00 € | ||
| 2mg | 90.00 € | ||
| 5mg | 125.00 € | ||
| 10mg | 193.00 € | ||
| 25mg | 343.00 € | ||
| 50mg | 510.00 € | ||
| 100mg | 732.00 € | ||
| 1mL*10mM (DMSO) | 140.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Telatinib
CAS:332012-40-5
Telatinib (Bay 57-9352) inhibits VEGFR2/3, c-Kit, PDGFRα with IC50s: 6 nM, 4 nM, 1 nM, …
Formula:
C20H16ClN5O3
Purity:
97.61% - 99.81%
Color and Shape:
Solid
Molecular weight:
409.83
Ref: TM-T6166
| 10mg | 39.00 € | ||
| 25mg | 78.00 € | ||
| 50mg | 113.00 € | ||
| 1mL*10mM (DMSO) | 34.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Altiratinib
CAS:1345847-93-9
Altiratinib (DCC-2701)(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor; effectively reduce tumor burden in vivo and block …
Formula:
C26H21F3N4O4
Purity:
98.98% - 99.39%
Color and Shape:
Solid
Molecular weight:
510.46
Ref: TM-T2054
| 5mg | 52.00 € | ||
| 10mg | 86.00 € | ||
| 25mg | 135.00 € | ||
| 50mg | 210.00 € | ||
| 100mg | 313.00 € | ||
| 1mL*10mM (DMSO) | 59.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
SU5408
CAS:15966-93-5
SU5408 (VEGFR2 Kinase Inhibitor I) is a potent, cell-permeable inhibitor of the VEGFR2 kinase.
Formula:
C18H18N2O3
Purity:
99.09%
Color and Shape:
Solid
Molecular weight:
310.35
Ref: TM-T4026
| 1mg | 69.00 € | ||
| 5mg | 184.00 € | ||
| 10mg | 277.00 € | ||
| 25mg | 508.00 € | ||
| 50mg | 686.00 € | ||
| 100mg | 886.00 € | ||
| 500mg | 1,748.00 € | ||
| 1mL*10mM (DMSO) | 205.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Gamabufotalin
CAS:465-11-2
Gamabufotalin, a Chansu bufadienolide, treats COX-2 diseases and cancer with high stability and low side …
Formula:
C24H34O5
Purity:
99.18% - 99.51%
Color and Shape:
Solid
Molecular weight:
402.52
Ref: TM-T4A2456
| 1mg | 114.00 € | ||
| 5mg | 235.00 € | ||
| 10mg | 411.00 € | ||
| 25mg | 675.00 € | ||
| 50mg | 922.00 € | ||
| 1mL*10mM (DMSO) | 125.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
WHI-P180
CAS:211555-08-7
WHI-P180 (Janex 3) is a potent EGFR and Cdk2 inhibitors with IC50 of 4.0 and …
Formula:
C16H15N3O3
Purity:
97.74%
Color and Shape:
Solid
Molecular weight:
297.31
Ref: TM-T2032
| 1mg | 46.00 € | ||
| 5mg | 87.00 € | ||
| 10mg | 131.00 € | ||
| 25mg | 215.00 € | ||
| 50mg | 321.00 € | ||
| 100mg | 463.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
SU 5402
CAS:215543-92-3
SU 5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 nM, …
Formula:
C17H16N2O3
Purity:
99.08% - 99.64%
Color and Shape:
Yellow-Green Solid
Molecular weight:
296.32
Ref: TM-T6996
| 5mg | 64.00 € | ||
| 10mg | 90.00 € | ||
| 25mg | 163.00 € | ||
| 50mg | 263.00 € | ||
| 100mg | 425.00 € | ||
| 1mL*10mM (DMSO) | 71.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
SKLB 610
CAS:1125780-41-7
SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2, and PDGFR at a …
Formula:
C21H16F3N3O3
Purity:
99.30% - 99.83%
Color and Shape:
Solid
Molecular weight:
415.37
Ref: TM-T1895
| 5mg | 44.00 € | ||
| 10mg | 79.00 € | ||
| 25mg | 116.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
SU5204
CAS:186611-11-0
SU5204 (3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one), an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for …
Formula:
C17H15NO2
Purity:
99.5%
Color and Shape:
Solid
Molecular weight:
265.31
Ref: TM-T22431
| 5mg | 34.00 € | ||
| 10mg | 51.00 € | ||
| 25mg | 84.00 € | ||
| 50mg | 112.00 € | ||
| 100mg | 174.00 € | ||
| 200mg | 256.00 € | ||
| 1mL*10mM (DMSO) | 37.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
N-Desethylsunitinib hydrochloride
CAS:1261432-05-6
N-Desethylsunitinib HCl, active sunitinib metabolite, inhibits VEGFR, PDGFRβ, KIT.
Formula:
C20H24ClFN4O2
Purity:
99.42%
Color and Shape:
Solid
Molecular weight:
406.88
Ref: TM-T12145L
| 1mg | 128.00 € | ||
| 5mg | 281.00 € | ||
| 10mg | 421.00 € | ||
| 25mg | 694.00 € | ||
| 50mg | 975.00 € | ||
| 1mL*10mM (DMSO) | 324.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Tivozanib
CAS:475108-18-0
Tivozanib (KRN951) is an oral VEGFRs 1-3 inhibitor with potential antiangiogenic and cancer-fighting properties.
Formula:
C22H19ClN4O5
Purity:
97.41% - 98.23%
Color and Shape:
Solid
Molecular weight:
454.86
Ref: TM-T2456
| 2mg | 40.00 € | ||
| 5mg | 60.00 € | ||
| 10mg | 82.00 € | ||
| 25mg | 141.00 € | ||
| 50mg | 234.00 € | ||
| 100mg | 420.00 € | ||
| 200mg | 616.00 € | ||
| 1mL*10mM (DMSO) | 67.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
Lariciresinol
CAS:27003-73-2
Lariciresinol: fungicidal enterolignan precursor with anti-tumor effects in breast cancer.
Formula:
C20H24O6
Purity:
99.46% - 99.84%
Color and Shape:
Solid
Molecular weight:
360.4
Ref: TM-TN1853
| 1mg | 166.00 € | ||
| 5mg | 404.00 € | ||
| 10mg | 592.00 € | ||
| 25mg | 915.00 € | ||
| 50mg | To inquire | ||
| 1mL*10mM (DMSO) | 415.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
AZD2932
CAS:883986-34-3
AZD2932 is a potent and multi-targeted kinase inhibitor VEGFR2, PDGFβ, Flt-3, and c-Kit.
Formula:
C24H25N5O4
Purity:
97.71% - 98.37%
Color and Shape:
Solid
Molecular weight:
447.49
Ref: TM-T1836
| 5mg | 38.00 € | ||
| 10mg | 56.00 € | ||
| 25mg | 93.00 € | ||
| 50mg | 150.00 € | ||
| 100mg | 232.00 € | ||
| 200mg | 344.00 € | ||
| 1mL*10mM (DMSO) | 43.00 € |
Estimated delivery in United States, on Monday 16 Dec 2024
